Breaking News, Collaborations & Alliances

MilliporeSigma, GlycoBac Enter Collaboration

Enables MilliporeSigma to offer first Sf-9 platform combining a rhabdovirus-free insect cell line with a cell culture medium

MilliporeSigma is collaborating with GlycoBac LLC to offer a Sf-9 insect cell line.    GlycoBac’s development of a proven rhabdovirus-negative (RVN) cell line enables MilliporeSigma to offer the first Sf-9 platform combining a rhabdovirus-free insect cell line with a corresponding, chemically defined cell culture medium. This will be the first non-mammalian cell line in MilliporeSigma’s cell culture portfolio, allowing customers worldwide access to a safer, high-performing vehicle for re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters